Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steve H Thorne

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Plos Medicine|December 29, 2007
Targeting of interferon-beta to produce a specific, multi-mechanistic oncolytic vaccinia virusDavid H Kirn, Yaohe Wang, Fabrice Le Boeuf, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 12, 2012
Crosstalk between immune cell and oncolytic vaccinia therapy enhances tumor trafficking and antitumor effectsPadma Sampath, Jun Li, Weizhou Hou, et al.
Neoplasia (New York, N.Y.)|January 12, 2013
Expression of CCL19 from oncolytic vaccinia enhances immunotherapeutic potential while maintaining oncolytic activityJun Li, Mark O'Malley, Padma Sampath, et al.
BMC Cancer|April 20, 2010
Role of nitric oxide in Salmonella typhimurium-mediated cancer cell killingYoram Barak, Frank Schreiber, Steve H Thorne, et al.
Nature Medicine|October 7, 2008
Chemical control of protein stability and function in living miceLaura A Banaszynski, Mark A Sellmyer, Christopher H Contag, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 21, 2008
Overcoming multidrug resistance of small-molecule therapeutics through conjugation with releasable octaarginine transportersElena A Dubikovskaya, Steve H Thorne, Thomas H Pillow, et al.
Cell Reports|April 7, 2016
Manipulating TLR Signaling Increases the Anti-tumor T Cell Response Induced by Viral Cancer TherapiesJuan J Rojas, Padma Sampath, Braulio Bonilla, et al.
Molecular Cancer Therapeutics|February 5, 2009
CNOB/ChrR6, a new prodrug enzyme cancer chemotherapySteve H Thorne, Yoram Barak, Wenchuan Liang, et al.
The Journal of Gene Medicine|October 27, 2011
Differential biodistribution of oncolytic poxvirus administered systemically in an autochthonous model of hepatocellular carcinomaPatrick Baril, Yann Touchefeu, Jeannette Cany, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 27, 2011
Chemokine expression from oncolytic vaccinia virus enhances vaccine therapies of cancerJun Li, Mark O'Malley, Julie Urban, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Plos Medicine|December 29, 2007
Targeting of interferon-beta to produce a specific, multi-mechanistic oncolytic vaccinia virusDavid H Kirn, Yaohe Wang, Fabrice Le Boeuf, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 12, 2012
Crosstalk between immune cell and oncolytic vaccinia therapy enhances tumor trafficking and antitumor effectsPadma Sampath, Jun Li, Weizhou Hou, et al.
Neoplasia (New York, N.Y.)|January 12, 2013
Expression of CCL19 from oncolytic vaccinia enhances immunotherapeutic potential while maintaining oncolytic activityJun Li, Mark O'Malley, Padma Sampath, et al.
BMC Cancer|April 20, 2010
Role of nitric oxide in Salmonella typhimurium-mediated cancer cell killingYoram Barak, Frank Schreiber, Steve H Thorne, et al.
Nature Medicine|October 7, 2008
Chemical control of protein stability and function in living miceLaura A Banaszynski, Mark A Sellmyer, Christopher H Contag, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 21, 2008
Overcoming multidrug resistance of small-molecule therapeutics through conjugation with releasable octaarginine transportersElena A Dubikovskaya, Steve H Thorne, Thomas H Pillow, et al.
Cell Reports|April 7, 2016
Manipulating TLR Signaling Increases the Anti-tumor T Cell Response Induced by Viral Cancer TherapiesJuan J Rojas, Padma Sampath, Braulio Bonilla, et al.
Molecular Cancer Therapeutics|February 5, 2009
CNOB/ChrR6, a new prodrug enzyme cancer chemotherapySteve H Thorne, Yoram Barak, Wenchuan Liang, et al.
The Journal of Gene Medicine|October 27, 2011
Differential biodistribution of oncolytic poxvirus administered systemically in an autochthonous model of hepatocellular carcinomaPatrick Baril, Yann Touchefeu, Jeannette Cany, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 27, 2011
Chemokine expression from oncolytic vaccinia virus enhances vaccine therapies of cancerJun Li, Mark O'Malley, Julie Urban, et al.
Pageof 4